Generic Name and Formulations:
Levobunolol HCl 0.5%; oph. soln; contains benzalkonium chloride.
Indications for BETAGAN:
1–2 drops of 0.5% 1–2 times daily.
Bronchial asthma. Severe COPD. Sinus bradycardia. 2nd- or 3rd-degree AV block. Overt cardiac failure. Cardiogenic shock.
Diabetes. Hyperthyroidism. Diminished pulmonary function. Angle-closure glaucoma. Myasthenia. Withdraw gradually before surgery. Discontinue at first sign of cardiac failure. Pregnancy (Cat.C). Nursing mothers.
Additive effects with systemic β-blockers, reserpine. Mydriasis with epinephrine.
Systemic absorption (bronchospasm, cardiac failure), transient ocular burning, stinging, blepharoconjunctivitis, bradycardia, hypotension, iridocyclitis, headache, transient ataxia, dizziness, lethargy, urticaria, pruritus, decreased corneal sensitivity.
Soln 0.5%— 5mL, 15mL
- 5ml of 0.5% eye droppers (Qty:2)
- appx. price $111.00
- Nine Factors That Appear to Elevate Alzheimer's Risk
- NSAIDs Linked to Long-Term Colon Cancer Risk Reduction
- Clinical Suspicion Leads to Uncommon Diagnosis in Patient With High Fever
- What a New Study Says About Omega-3s and Brain Health
- Measles and 'Immune Amnesia': Why Vaccination Could Also Prevent Other Diseases